The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr 348 phosphorylation
Open accessPreprint — published as 10.1007/s00401-019-02017-9 · Paper page
Abstract
The bridging integrator 1 gene ( BIN1 ) is a major genetic risk factor for Alzheimer’s disease (AD). In this report, we investigated how BIN1-dependent pathophysiological processes might be associated with Tau. We first generated a cohort of control and transgenic mice either overexpressing human MAPT (Tg MAPT ) or both human MAPT and BIN1 (Tg MAPT ;Tg BIN1 ), which we followed-up from 3 to 15 months. In Tg MAPT ;Tg BIN1 mice short-term memory deficits appeared earlier than in Tg MAPT mice; however – unlike Tg MAPT mice – Tg MAPT ;Tg BIN1 mice did not exhibit any long-term or spatial memory deficits for at least 15 months. After sacrifice of the cohort at 18 months, immunohistochemistry revealed that BIN1 overexpression prevents both Tau mislocalization and somatic inclusion in the hippocampus, where an increase in BIN1-Tau interaction was also observed. We then sought mechanisms controlling the BIN1-Tau interaction. We developed a high-content screening approach to characterize modulators of the BIN1-Tau interaction in an agnostic way (1,126 compounds targeting multiple pathways), and we identified – among others – an inhibitor of Calcineurin, a Ser/Thr phosphatase. We determined that Calcineurin dephosphorylates BIN1 on a Cyclin-dependent kinase phosphorylation site at T348, promoting the open conformation of the neuronal BIN1 isoform. Phosphorylation of this site increases the availability of the BIN1 SH3 domain for Tau interaction, as demonstrated by nuclear magnetic resonance experiments and in primary neurons. Finally, we observed that the levels of the neuronal BIN1 isoform were decreased in AD brains, whereas phospho-BIN1(T348):BIN1 ratio was increased, suggesting a compensatory mechanism. In conclusion, our data support the idea that BIN1 modulates the AD risk through an intricate regulation of its interaction with Tau. Alteration in BIN1 expression or activity may disrupt this regulatory balance with Tau and have direct effects on learning and memory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Human BIN1 overexpression in a mouse model of tauopathy increases BIN1-Tau interaction in the neuronal network and rescues long-term memory deficits and Tau somatic inclusions induced by human Tau overexpression.
“human BIN1 overexpression in a mouse model of tauopathy has been shown to increase BIN1–Tau interaction in the neuronal network and to rescue long-term memory deficits and Tau somatic inclusions induced by human Tau overexpression [110].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [110]
Human BIN1 directly binds Tau, and this interaction in neurons depends on the level of BIN1 expression and the phosphorylation statuses of both BIN1 and Tau.
“human BIN1 directly binds Tau and this interaction in neurons depends on the level of BIN1 expression, as well as the phosphorylation statuses of both BIN1 and Tau [85, 89, 110, 124].”
From The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? (2019) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ARUK Consortium, Sims, R., GERAD/PERADES, C., van der Lee, S. J., Naj, A. C., Bellenguez, C., Badarinarayan, N., Jakobsdottir, J., Kunkle, B. W., Boland, A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3916 · Cited by 1,012
Self-citation
Flagged first, then by citations
Research works printed but not linked: 50
- 10.1016/j.jalz.2012.11.007 · DOI · Paper page
- 10.1016/j.tins.2014.08.004 · DOI
- 10.1126/science.1072994 · DOI · Paper page
- 10.1001/archpsyc.63.2.168 · DOI · Paper page
- 10.1038/ng.803 · DOI · Paper page
- 10.1038/ng.439 · DOI · Paper page
- 10.1038/ng.2802 · DOI · Paper page
- 2010, Deciphering genetic susceptibility to frontotemporal lobar dementia, Nat Genet, 42, 189, 10.1038/ng0310-189 · DOI
- 10.1038/mp.2016.59 · DOI · Paper page
- 10.1016/j.ajhg.2011.01.006 · DOI
- 10.1093/hmg/ddt478 · DOI · Paper page
- 10.1371/journal.pgen.1004606 · DOI · Paper page
- 2013, GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer’s disease, Neuron, 78, 256, 10.1016/j.neuron.2013.02.026 · DOI · Paper page
- 10.1097/NEN.0b013e31825018f7 · DOI · Paper page
- 2018, Cognitive Decline in Preclinical Alzheimer’s Disease: Amyloid-Beta versus Tauopathy, J Alzheimers Dis, 61, 265
- 10.1038/mp.2013.1 · DOI · Paper page
- 10.1007/s00109-014-1138-1 · DOI · Paper page
- 10.1083/jcb.137.6.1355 · DOI · Paper page
- 10.1074/jbc.272.26.16700 · DOI · Paper page
- Daudin, R. , Marechal, D. , Wang, Q. et al. BIN1 genetic risk factor for Alzheimer is sufficient to induce early structural tract alterations in entorhinal cortex-dentate gyrus pathway and related hippocampal multi-scale impairments. bioRxiv (2018). · DOI · Paper page
- 10.1186/s13024-016-0124-1 · DOI · Paper page
- 10.1093/hmg/ddw146 · DOI · Paper page
- 2017, Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease, Mol Neurodegener, 12, 82, 10.1186/s13024-017-0219-3 · DOI · Paper page
- 10.1016/j.celrep.2016.09.063 · DOI · Paper page
- 10.1111/febs.14185 · DOI · Paper page
- 10.1523/JNEUROSCI.1065-09.2009 · DOI · Paper page
- 10.1046/j.1471-4159.2003.01879.x · DOI · Paper page
- 10.1523/JNEUROSCI.4637-04.2005 · DOI · Paper page
- 10.1016/S0165-0173(00)00019-9 · DOI
- 2015, Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domain, Acta Neuropathol Commun, 3, 58, 10.1186/s40478-015-0237-8 · DOI · Paper page
- 10.1074/jbc.272.49.30984 · DOI
- 10.1074/jbc.M008932200 · DOI
- Lasorsa, A. , Malki, I. , Cantrelle, F.X. et al. Structural basis of Tau interaction with BIN1 and regulation by Tau phosphorylation. Front Mol Neurosci 11, 421. · DOI · Paper page
- 10.1074/jbc.M115.700914 · DOI
- 10.1073/pnas.0406344101 · DOI · Paper page
- 10.1093/cercor/bhs033 · DOI · Paper page
- 2017, Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism, Acta Neuropathol, 133, 955, 10.1007/s00401-016-1652-z · DOI · Paper page
- 10.1371/journal.pone.0078806 · DOI · Paper page
- 10.3233/JAD-132450 · DOI · Paper page
- 2018, Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: The forgotten partner, Prog Neurobiol, 169, 24, 10.1016/j.pneurobio.2018.07.004 · DOI
- 10.1038/82868 · DOI · Paper page
- 10.1038/nprot.2012.099 · DOI
- 10.1038/nprot.2006.356 · DOI
- 2015, Analysis of autophagosome formation using lentiviral biosensors for live fluorescent cellular imaging, Methods Mol Biol, 1219, 157, 10.1007/978-1-4939-1661-0_12 · DOI
- 10.1007/s00401-006-0127-z · DOI · Paper page
- 2013, Elucidation of the BACE1 regulating factor GGA3 in Alzheimer’s disease, J Alzheimers Dis, 37, 217, 10.3233/JAD-130104 · DOI
- 2005, Methods for preparation of proteins and protein complexes that regulate the eukaryotic cell cycle for structural studies, Methods Mol Biol, 296, 219
- 10.1007/978-1-4939-2742-5_15 · DOI
- 10.1016/j.ymeth.2008.06.014 · DOI
- Gomes, I. , Sierra, S. & Devi, L.A. Detection of Receptor Heteromerization Using In Situ Proximity Ligation Assay. Curr Protoc Pharmacol 75, 2.16.11-12.16.31 (2016). · DOI
Cited by
Sorted by citations
Dourlen, P., Kilinc, D., Malmanche, N., Chapuis, J., & Lambert, J.-C. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02004-0 · Cited by 168
Self-citation
Metadata
- Authors
- Sartori, M., Mendes, T., Desai, S., Lasorsa, A., Herledan, A., Malmanche, N., Mäkinen, P., Marttinen, M., Malki, I., Chapuis, J., Flaig, A., Vreulx, A.-C., Amouyel, P., Leroux, F., Déprez, B., Cantrelle, F.-X., Maréchal, D., Pradier, L., Hiltunen, M., Landrieu, I., Kilinc, D., Herault, Y., Laporte, J., & Lambert, J.-C.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- University of Eastern Finland (FI)
- Sanofi (France) (FR)
- Corresponding author
- Laporte, Jocelyn
- Lambert, Jean-Charles
- ORCID
- Venue
- Acta Neuropathologica
- Publisher
- openRxiv
- Published
- 2018-11-07
- Volume
- 138
- Issue
- 4
- Pages
- 631-652
- ISSN
- 0001-6322 (ISSN-L)
- PMC
- PMC6778065
- OpenAlex
- W2951997054
- Cited by
- 72
- References
- 1
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 12 · 2021: 11 · 2020: 9 · 2019: 7
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- Alzheimer's Association (BFG-14-318355)
- Sanofi
- Itä-Suomen Yliopisto
- EU Joint Programme – Neurodegenerative Disease Research (3DMiniBrain)
- Fondation Vaincre Alzheimer
- Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease
- Université de Lille
- Equipex
- Agence Nationale de la Recherche (10 IDEX 0002, ANR-10-INBS-07, ANR-10-IDEX-0002, ANR-11-LABX-0009, 10-INBS-07694, ANR-10-LABX-0030, ANR-15-CE16-0002, ANR-10, ANR-10-LABX, ANR-10-INBS-0007, 15-CE-16-0002)
- Institut National de la Santé et de la Recherche Médicale (ANR-10-INBS-07, ANR‐10‐LABX‐0030‐INRT)
- Academy of Finland (307866)
- Association Nationale de la Recherche et de la Technologie
- Université de Strasbourg (10-IDEX-0002, ANR-10-LABX-0030, ANR-10-LABX-0030-INRT)
- Centre National de la Recherche Scientifique (ANR-10-LABX-0030-INRT, FR‐3688)
- Sigrid Juséliuksen Säätiö (307866)
- Institute Pasteur De Lille
- PHENOMIN (ANR-10-INBS-07)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- BIN1, tauopathy, Alzheimer's disease, tau phosphorylation, calcineurin, cyclin-dependent kinases, SH3 domain, long-term memory deficits, short-term memory impairment, hippocampus, transgenic mice, high-content screening
- MeSH terms
- Alzheimer Disease, Animals, Brain, Memory Disorders, Mice, Transgenic, Nerve Tissue Proteins, Neurons, Phosphorylation, tau Proteins, Tauopathies, Tumor Suppressor Proteins, Adaptor Proteins, Signal Transducing, Mice, Memory, Long-Term, Spatial Memory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review